![Jennifer Creel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jennifer Creel worked as Vice President-Global Finance & Business Planning at Celgene Corp.
from 2008 to 2020.
She then worked as Chief Financial Officer at ADC Therapeutics SA from 2020 to 2022.
Ms. Creel received an undergraduate degree from The College of William & Mary and an MBA from the University of Virginia Darden School of Business.
Anciens postes connus de Jennifer Creel
| Sociétés | Poste | Fin |
|---|---|---|
| ADC THERAPEUTICS SA | Directeur Financier/CFO | 19/12/2022 |
| CELGENE | Corporate Officer/Principal | 01/01/2020 |
Formation de Jennifer Creel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
